Abstract
The identification and characterization of the inducible form of cyclooxygenases (COX-2) stimulated the investigations to develop efficient, non-steroidal anti-inflammatory drugs (NSAIDs) with reduced side effects (essentially gastro-intestinal toxicity) compared to classical NSAIDs. This review focuses on the chemical and pharmacological properties (pre-clinical data) of marketed COX-2 inhibitors.
Keywords: cox-2 inhibitors, cox-2 selectivity, pre-clinical data
Mini-Reviews in Medicinal Chemistry
Title: First and Second Generations of COX-2 Selective Inhibitors
Volume: 4 Issue: 6
Author(s): Xavier de Leval, Fabien Julemont, Valerie Benoit, Michel Frederich, Bernard Pirotte and Jean-Michel Dogne
Affiliation:
Keywords: cox-2 inhibitors, cox-2 selectivity, pre-clinical data
Abstract: The identification and characterization of the inducible form of cyclooxygenases (COX-2) stimulated the investigations to develop efficient, non-steroidal anti-inflammatory drugs (NSAIDs) with reduced side effects (essentially gastro-intestinal toxicity) compared to classical NSAIDs. This review focuses on the chemical and pharmacological properties (pre-clinical data) of marketed COX-2 inhibitors.
Export Options
About this article
Cite this article as:
Leval de Xavier, Julemont Fabien, Benoit Valerie, Frederich Michel, Pirotte Bernard and Dogne Jean-Michel, First and Second Generations of COX-2 Selective Inhibitors, Mini-Reviews in Medicinal Chemistry 2004; 4 (6) . https://dx.doi.org/10.2174/1389557043403693
DOI https://dx.doi.org/10.2174/1389557043403693 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Current Concepts and Future Directions in Radioimmunotherapy
Current Drug Discovery Technologies Irbesartan: Second Generation of ARB as Metabosartan
Current Hypertension Reviews Nitric Oxide-Releasing Nonsteroidal Anti-inflammatory Drugs Novel Gastrointestinal-Sparing Drugs
Mini-Reviews in Medicinal Chemistry Isolation, Characterization, and Docking Studies of (Z)-Isopropyl 7-((1R, 2R, 3R, 5S)- 2-((1E, 3Z)-3-Fluoro-4-Phenoxybuta-1, 3-Dienyl)-3,5-Dihydroxycyclopentyl) Hept-5- Enoate, an Impurity of Tafluprost
Current Organic Synthesis Development of Extracellular Signal-Regulated Kinase Inhibitors
Current Topics in Medicinal Chemistry Upregulation of Connexin-43 is Critical for Irradiation-induced Neuroinflammation
CNS & Neurological Disorders - Drug Targets alpha Conotoxins Nicotinic Acetylcholine Receptor Antagonists as Pharmacological Tools and Potential Drug Leads
Current Medicinal Chemistry Epithelial-Mesenchymal Transition as a Therapeutic Target for Prevention of Ocular Tissue Fibrosis
Endocrine, Metabolic & Immune Disorders - Drug Targets The Effect of Apium Nodiflorum in Experimental Osteoporosis
Current Pharmaceutical Biotechnology Pharmaceutical and Biomedical Potential of PEGylated Dendrimers
Current Pharmaceutical Design Prostacyclin Synthase Gene: Genetic Polymorphisms and Prevention of Some Cardiovascular Diseases
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Meet Our Editorial Board Member:
Current Nutrition & Food Science The Role of Alterations in Arachidonic Acid Metabolism and Nitric Oxide Homeostasis in Rat Models of Diabetes During Early Pregnancy
Current Pharmaceutical Design Modulation of Immuno-biome during Radio-sensitization of Tumors by Glycolytic Inhibitors
Current Medicinal Chemistry Genetic Modifications of Icosahedral Plant Virus-based Nanoparticles for Vaccine and Immunotherapy Applications
Current Protein & Peptide Science Treatment of Chronic Myeloid Leukemia Elderly Patients in the Tyrosine Kinase Inhibitor Era
Current Cancer Drug Targets Oxidative Stress, Inflammation and Endothelial Biomarkers in Arterial Hypertension
Current Hypertension Reviews Genetic Approaches for Antigen-Selective Cell Therapy
Current Gene Therapy Hydroxysafflor Yellow A Attenuates Renal Ischemia- Reperfusion Injury in a Rat Model
Letters in Drug Design & Discovery Hydrogen Commonly Applicable from Medicine to Agriculture: From Molecular Mechanisms to the Field
Current Pharmaceutical Design